摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

11,17,21-三羟基-3,20-二氧代孕甾烷-1,4-二烯-16-羧酸甲酯 | 111802-47-2

中文名称
11,17,21-三羟基-3,20-二氧代孕甾烷-1,4-二烯-16-羧酸甲酯
中文别名
——
英文名称
P16CM
英文别名
methyl 11β,17α,21-trihydroxy-3,20-dioxo-pregna-1,4-diene-16α-carboxylate;methyl 11β,17α,21-trihydroxy-3,20-dioxo-1,4-pregnadiene 16α-carboxylate;16α-methoxycarbonyl prednisolone;11β,17α,21-trihydroxy-16α-methoxy-carbonyl-3,20-dioxo-1,4-pregnadiene;Methyl prednisolone-16alpha-carboxylate;methyl (8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-16-carboxylate
11,17,21-三羟基-3,20-二氧代孕甾烷-1,4-二烯-16-羧酸甲酯化学式
CAS
111802-47-2
化学式
C23H30O7
mdl
——
分子量
418.487
InChiKey
SNIXVWCOGOOOGH-UAHQIDPDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    30
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    121
  • 氢给体数:
    3
  • 氢受体数:
    7

SDS

SDS:66f5ef2fea963d57669300a329141172
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Suppression of the Mattox rearrangement of 16α-cyanoprednisolones in acid: Synthesis of methyl 16α-prednisolonecarboxylates
    作者:Zhengqing You、Mounir A. Khalil、Dong-Hoon Ko、Henry J. Lee
    DOI:10.1016/0040-4039(95)00526-i
    日期:1995.5
    addition of fulminic acid to 21-acetyloxy-11β-hydroxy-3,20-dioxo-1,4,16-pregnatriene, followed by base-catalyzed ring opening of the resulting isoxazoline to yield a 16α-cyanoprednisolone derivative and treatment of the nitrile with methanolic HCl. Conversion of the cyanosteroids in the acid to the corresponding methyl carboxylates was achieved with or without the Mattox rearrangement by controlling reaction
    通过将新的1,3-偶极海藻酸加至21-乙酰氧基-11β-羟基-3,20-dioxo-1,4,16-孕三烯的新方法合成具有16α-羧酸甲酯基的泼尼松龙生物,然后所得异恶唑啉的碱催化的开环,得到16α-间苯二酚生物,并用甲醇的HCl处理腈。通过控制21-OH的反应温度和保护基团,在有或没有Mattox重排的情况下,将酸中的基类固醇转化为相应的羧酸甲酯。
  • New steroidal anti-inflammatory antedrugs: methyl 21-desoxy-21-chloro-11β,17α-dihydroxy-3,20-dioxo-1,4-pregnadiene-16α-carboxylate, methyl 21-desoxy-21-chloro-11β-hydroxy-3,20-dioxo-1,4-pregnadiene-16α-carboxylate, and their 9α-fluoro derivatives⋆
    作者:D Ko
    DOI:10.1016/s0039-128x(99)00103-8
    日期:2000.4
    To a series of 21-desoxy-21-chloro-corticosteroids, a metabolically labile methoxycarbonyl group at C-16 has been incorporated The approach is to synthesize locally active compounds that are hydrolyzed to inactive and readily excretable acid metabolites upon entry into the systemic circulation. Novel antedrugs were evaluated for anti-inflammatory activity and their adverse effects in an acute and semichronic croton oil-induced ear edema bioassay. Binding affinity to glucocorticoid receptors and induction of L-tyrosine-2-oxoglutarate aminotransferase were studied in hepatoma tissue culture cells. After a single topical application in the croton oil-induced ear edema bioassay, treatment with all the compounds resulted in dose-dependent inhibition of edema. From these dose-response profiles, the following ID50 values (nmol/year resulting in a 50% reduction of edema) were calculated: 540, 618, 454, and 346 nmol for prednisolone (P), methyl 21-desoxy-21-chloro-11 beta,17 alpha-dihydroxy-3,20-dioxo-1,4-pregnadien-16 alpha-carboxylate (PClCM), methyl 21-desoxy-21-chloro-11 beta, 17 alpha-dihydroxy-9 alpha-fluoro-3,20-dioxo-1,4-pregnadien-16 alpha-carboxylate (FPClCM), and methyl 21-desoxy-21-chloro-9 alpha-fluoro-11 beta-hydroxy-3,20-dioxo-1,4-pregnadien-16 alpha-carboxylate (FDPClCM), respectively. Results of the 5-day rat croton oil ear edema bioassay indicated that, in contrast with the parent compound P, the novel steroidal antedrugs did not significantly alter body weight gain, thymus weights, or plasma corticosterone levels. The binding affinities for cytosolic hepatoma tissue culture glucocorticoid receptors were 33, 201, 471, 5304, and 3765 nM for P, PClCM, FPClCM, methyl 21-desoxy-21-chloro-11 beta-hydroxy-3,20-dioxo-1,4-pregnadien-16 alpha-carboxylate (DPClCM), and FDPClCM, respectively. Collectively, results of these investigations suggest that modifications of P, which included replacement of 21-hydroxyl group with chlorine and addition of 16-methoxycarbonyl group with or without 17-hydroxyl moiety, retained the topical anti-inflammatory activity of the parent compound P without significant adverse systemic effects. (C) 2000 Elsevier Science Inc. All rights reserved.
  • HEIMAN, ANN S.;TARAPOREWALA, IRACH B.;MCLEAN, HUGH M.;HONG, DEASIK;LEE, H+, J. PHARM. SCI., 79,(1990) N, C. 617-621
    作者:HEIMAN, ANN S.、TARAPOREWALA, IRACH B.、MCLEAN, HUGH M.、HONG, DEASIK、LEE, H+
    DOI:——
    日期:——
  • US4762919A
    申请人:——
    公开号:US4762919A
    公开(公告)日:1988-08-09
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B